Il prossimoProssima guida
L'intelligenza artificiale nelle telecomunicazioni
Industrie
GUIDA alle industrie
AI in pharmaceutical work can support discovery, clinical development, manufacturing, safety monitoring, and regulatory analysis.
Ascolta questa guidaNarrato dall'IA · ~2 min
Evidence must match the context of use and the consequences of error. A promising retrospective model is not automatically credible for a clinical or regulatory decision.
Define the intended use, population, endpoint, and decision boundary. A model prioritizing compounds for laboratory study differs from one used to inform a clinical submission. Preserve the distinction between exploratory hypotheses and evidence used to support safety or effectiveness. Use documented data provenance, quality controls, and appropriate validation. Check batch effects, missing measurements, site differences, and whether the outcome label is a meaningful proxy. For time-dependent or prospective decisions, use evaluation data that respects when information becomes available. FDA and EMA guiding principles emphasize human-centered design, risk-based approaches, context of use, multidisciplinary expertise, data governance, performance assessment, and lifecycle management. Treat these as a framework for evidence and accountability, not as a blanket approval of a model. Retain versioned protocols, model outputs, and review decisions. Monitor performance after deployment and define how a change in data, assay, or model triggers reassessment.
04Esempio lavorato
Imagine a model ranking ten compounds for laboratory testing with a strong retrospective score.
Before using it for a patient-safety decision, define the prospective endpoint and evaluate on data collected under that protocol.
Record the uncertainty and require domain review at the new decision boundary.
Cosa mostra
The constructed example separates exploratory prioritization from regulated evidence.
Hold out a study site when evaluating whether a biomarker model transfers.
Document context of use before using an AI result in a regulated submission.
Newsletter gratuita
Tre storie verificate sull'IA ogni mattina nei giorni feriali, scritte in un inglese semplice. Gratuito per sempre, senza pubblicità.
Un'email ogni giorno feriale. Disiscriviti con un clic. Non vendiamo né condividiamo mai il tuo indirizzo.
Mettiti alla prova
Feedback immediato su ogni risposta e un certificato condivisibile con un ID verificabile una volta superato un corso.
Sostieni l'istruzione gratuita sull'IA. AI Understanding è un'organizzazione non profit 501(c)(3) — nessun annuncio, nessun paywall, mai. Fai una donazione
No. Evidence requirements depend on the intended use, data, endpoint, and risk of the decision.
Continua a imparare
Altre guide selezionate per questo argomento
Il prossimoProssima guida
L'intelligenza artificiale nelle telecomunicazioni
Industrie